ACO Name and Location

Covenant ACO, Inc.
Previous Legal Business Entity Name: Covenant Health Partners, Inc.
3615 19th St
Lubbock, Texas 79410

ACO Primary Contact

Nathan Taylor
(806) 725-3296
Nathan.Taylor@stjoe.org

Organizational Information

ACO Participants:

ACO Governing Body:

Member			Member's Voting Power – Expressed as a percentage or number	Membership Type	ACO Participant Legal Business Name/DBA, if Applicable
Last Name	First Name	Title/Position
Snodgrass	Brad	Chair	0	ACO Participant Representative	Covenant Medical Group
Crossnoe	Chetlen	Vice Chair	1	ACO Participant Representative	Grace Clinic of Lubbock
Brown	Jeremy	Member	1	ACO Participant Representative	Covenant Medical Group
Collins	Christopher	Member	1	ACO Participant Representative	Grace Clinic of Lubbock
Dalton	Jeremy	Member	1	ACO Participant Representative	Covenant Medical Group
Ferguson	Angela	Member	1	ACO Participant Representative	Covenant Medical Group
Gadwala	Swetha	Member	1	ACO Participant Representative	Neurosurgical Associates LLP
Hannel	Jeffrey	Member	1	ACO Participant Representative	Grace Clinic of Lubbock
Henderson	Richard	Member	1	ACO Participant Representative	Covenant Medical Group
Hill	Joshua	Member	1	ACO Participant Representative	Covenant Medical Group
Landry	Joel	Member	1	ACO Participant Representative	Covenant Medical Group
Nall	Brent	Member	1	ACO Participant Representative	Grace Clinic of Lubbock
Owen	Ryan	Member	1	ACO Participant Representative	Covenant Medical Group
Patel	Nilesh	Member	1	ACO Participant Representative	Covenant Medical Group
Rohra	Lakhu	Member	1	ACO Participant Representative	Lakhu J. Rohra, MD
Rozean	Randy	Member	1	ACO Participant Representative	Family First HealthCare
Soriano	Karen	Member	1	ACO Participant Representative	Covenant Medical Group
Sorrell	Cari	Member	1	ACO Participant Representative	Texas Digestive Disease Consultants
Strefling	Jason	Member	1	ACO Participant Representative	Covenant Medical Group
Yates	Marissa	Member	1	ACO Participant Representative	Covenant Medical Group
Deshan	Preston	Member	0	Medicare Beneficiary Representative	N/A
Kimble	Roger	Member	0	Medicare Beneficiary Representative	N/A
Rogers	Kelly	Member	0	Medicare Beneficiary Representative	N/A
Franklin	Linda	Member	0	Medicare Beneficiary Representative	N/A
Neal	Nancy	Member	0	Medicare Beneficiary Representative	N/A
Shropshire	Jack	Member	0	Medicare Beneficiary Representative	N/A
Zwiacher	Ann	Member	0	Medicare Beneficiary Representative	N/A

Key ACO Clinical and Administrative Leadership:

Title	Name
ACO Executive	Michael Robertson, MD
Medical Director	Michael Robertson, MD
Compliance Officer	Nathan Taylor
Quality Assurance/Improvement Officer	Lisa Barrington

Associated Committees and Committee Leadership:

Committee Name	Committee Leader Name and Position
Credentials Committee	Dr. Jeremy Brown, Chair
Population Health Committee	Dr. Randolph Rozean, Chair
Quality & Performance Committee	Dr. Brad Snodgrass, Chair

Types of ACO Participants, or Combinations of Participants, That Formed the ACO:

• Networks of individual practices of ACO professionals
• Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses:

• Third Agreement Period
  • Performance Year 2021, $3,392,164
  • Performance Year 2020, $2,467,947
• Second Agreement Period
  • Performance Year 2019, -$688,512
  • Performance Year 2018, $2,415,533
  • Performance Year 2017, $282,266
• First Agreement Period
  • Performance Year 2016, $2,659,327
  • Performance Year 2015, $0
  • Performance Year 2014, $2,542,945

Shared Savings Distribution:

• Third Agreement Period
  • Performance Year 2021 - (preliminary, will be finalized in Oct 2022)
    • Proportion invested in infastructure: 25%
    • Proportion invested in redesigned care processes/resources: 25%
    • Proportion of distribution to ACO participants: 50%
  • Performance Year 2020
    • Proportion invested in infastructure: 26%
    • Proportion invested in redesigned care processes/resources: 20%
    • Proportion of distribution to ACO participants: 54%
• Second Agreement Period
  • Performance Year 2019
    • Proportion invested in infastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2018
    • Proportion invested in infastructure: 17%
    • Proportion invested in redesigned care processes/resources: 35%
    • Proportion of distribution to ACO participants: 48%
  • Performance Year 2017
    • Proportion invested in infastructure: 25%
    • Proportion invested in redesigned care processes/resources: 8%
    • Proportion of distribution to ACO participants: 66%
• First Agreement Period
  • Performance Year 2016
    • Proportion invested in infrastructure: 25%
    • Proportion invested in redesigned care processes/resources: 8%
    • Proportion of distribution to ACO participants: 66%
  • Performance Year 2015
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2014
    • Proportion invested in infrastructure: 25%
    • Proportion invested in redesigned care processes/resources: 25%
    • Proportion of distribution to ACO participants: 50%

Quality Performance Results

2021 Quality Performance Results:

Quality performance results are based on CMS Web Interface

Measure ID	Measure Name	Rate	All ACOs
CAHPS-1	Getting Timely Care, Appointments, and Information	85.37	84.67
CAHPS-2	How Well Your Providers Communicate	92.04	93.56
CAHPS-3	Patients’ Rating of Provider	92.97	92.19
CAHPS-4	Access to Specialists	80.84	78.80
CAHPS-5	Health Promotion and Education	56.97	61.61
CAHPS-6	Shared Decision Making	56.87	60.89
CAHPS-7	Health Status and Functional Status	71.85	71.78
CAHPS-8	Care Coordination	84.40	85.66
CAHPS-9	Courteous and Helpful Office Staff	89.86	91.88
CAHPS-11	Stewardship of Patient Resources	26.79	24.71
001	Diabetes: Hemoglobin A1c (HbA1c) Poor Control	13.07	12.46
134	Preventative Care and Screening: Screening for Depression and Follow-up Plan	59.30	74.38
236	Controlling High Blood Pressure	72.24	74.87
318	Falls: Screening for Future Fall Risk	82.92	87.03
110	Preventive Care and Screening: Influenza Immunization	82.50	80.52
226	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention	77.27	80.97
113	Colorectal Cancer Screening	72.33	73.63
112	Breast Cancer Screening	74.76	75.11
438	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	80.74	84.24
479	Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups	0.1333	0.1540
MCC1	All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC)	24.13	33.99

• Please note, the Quality ID # 370 Depression Remission at 12 Months quality measure is not included in public reporting due to low sample size.
• For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Payment Rule Waivers:

• Skilled Nursing Facility (SNF) 3-Day Rule Waiver:
  • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR §425.612.
• Waiver for Payment for Telehealth Services
  • Our ACO clinicians do provide telehealth services using the flexibilities under 42 CFR §425.612(f) and 42 CFR §425.613.